Common Stock, Shares, Outstanding of INOVIO PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
INOVIO PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • INOVIO PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 68,996,647, a 91% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

INOVIO PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 68,996,647 +32,896,656 +91% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 53,571,675 +27,519,223 +106% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 36,718,527 +10,754,983 +41% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 36,674,355 +13,303,102 +57% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 36,099,991 +13,306,916 +58% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 26,052,452 -243,679,029 -90% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 25,963,544 -242,109,658 -90% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 23,371,253 -239,367,873 -91% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 22,793,075 +1,702,137 +8.1% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 269,731,481 +20,246,217 +8.1% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 268,073,202 +20,568,655 +8.3% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 262,739,126 +36,228,406 +16% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 21,090,938 -196,291,949 -90% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 249,485,264 +39,122,430 +19% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 247,504,547 +37,357,667 +18% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 226,510,720 +17,176,684 +8.2% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 217,382,887 +30,531,394 +16% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 210,362,834 +42,834,399 +26% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 210,146,880 +51,390,469 +32% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 209,334,036 +63,418,936 +43% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 186,851,493 +85,490,459 +84% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 167,528,435 +68,482,277 +69% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 158,756,411 +60,172,040 +61% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 145,915,100 +47,981,090 +49% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 101,361,034 +4,135,224 +4.3% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 99,046,158 +4,573,769 +4.8% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 98,584,371 +7,109,976 +7.8% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 97,934,010 +7,229,079 +8% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 97,225,810 +6,868,166 +7.6% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 94,472,389 +4,177,452 +4.6% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 91,474,395 +13,840,579 +18% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 90,704,931 +16,077,918 +22% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 90,357,644 +16,295,274 +22% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 90,294,937 +16,328,207 +22% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 77,633,816 +4,150,957 +5.6% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 74,627,013 +2,358,830 +3.3% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 74,062,370 +1,844,405 +2.6% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 73,966,730 +1,785,936 +2.5% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 73,482,859 +1,672,673 +2.3% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 72,268,183 +11,527,101 +19% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 72,217,965 +11,476,883 +19% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 72,180,794 +11,722,854 +19% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 71,810,186 +11,492,507 +19% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 60,741,082 -179,405,261 -75% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 60,741,082 +8,164,692 +16% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q3 2014 60,457,940 -147,162,097 -71% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 60,317,679 -119,740,926 -67% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 240,146,343 +60,205,482 +33% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 52,576,390 -91,736,615 -64% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 207,620,037 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 180,058,605 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 179,940,861 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 144,313,005 +9,344,611 +6.9% 31 Dec 2012 10-K 17 Mar 2014 2013 FY
Q4 2011 134,968,394 +29,930,202 +28% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q4 2010 105,038,192 31 Dec 2010 10-K 15 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.